XTL BIOPHARMACEUTICALS LTD.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -81.8% | -81.8% | -45.4% |
| FY2021 | 8.2% | 8.2% | 6.6% |
| FY2022 | -33.7% | -33.7% | -32.2% |
| FY2023 | -80.3% | -80.3% | -73.5% |
| FY2024 | -18.9% | -18.9% | -12.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -81.8% | -81.8% | -45.4% |
| FY2021 | 8.2% | 8.2% | 6.6% |
| FY2022 | -33.7% | -33.7% | -32.2% |
| FY2023 | -80.3% | -80.3% | -73.5% |
| FY2024 | -18.9% | -18.9% | -12.0% |